How to predict subclinical atherosclerosis in systemic lupus erythematosus Does non-invasive imaging hold the key?
activity and duration, may predict subclinical ATS, an asymptomatic but potentially dangerous condition.
Several invasive and non-invasive imaging techniques may be useful in assessing endothelial dysfunction and arterial stiffness. Unfortunately, while wide variation in reproducibility is reported in endothelial function measurements, due to both differences in technical protocols and the impact of physiological factors on flow-mediated dilation, this variation is considerably less when measuring IMT. We prefer to use non-invasive techniques, such as sonography-based techniques (equipped with an internal ECG monitor), because they are less expensive, easy to use and easily tolerated by patients.
We showed the presence of increased stiffness parameters in SLE patients with normal IMT (<0.6 mm) by means of an M-Mode ultrasonography with synchronous ECG measuring the major increase and reduction in the vessel diameter of the common carotid artery during heart cycles, applying the equations shown in Fig. 1 .
Clinical ATS (change in plaque echogenicity and plaque progression) is efficiently revealed and monitored by sonography and pulse-wave Doppler sonography, respectively. However, to prevent clinical ATS, strategies should rely on identification of subclinical ATS through the screening of early established markers of cardiovascular risk such as endothelial dysfunction, vascular stiffness and IMT.
Monitoring of carotid IMT excellently evaluates risk stratification in hypertensive patients, pharmacological efficacy in clinical trials and rate of progression of ATS before the formation of plaque. A meta-analysis showed that IMT significantly increased in populations with SLE disease compared with age-and sex-matched healthy controls [8] . IMT is a surrogate marker for atherosclerotic disease when deciding therapeutic strategies in lupusmediated atherogenesis [9] .
However, a debatable point is that SLE and control subjects may show similar values of carotid IMT, which is reported in several studies [10] . Moreover, a significantly lower mean IMT but a higher prevalence of plaque in SLE compared with control subjects was observed.
On the basis of physiopathology and according to some authors [4, 7] , endothelial dysfunction and vascular stiffness precede the increase of IMT in subclinical ATS; they may be viewed as important predictors of subclinical ATS 
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in SLE. Therefore, because subclinical ATS develops at an earlier age in patients with SLE than in controls, endothelial dysfunction and vascular stiffness should also be evaluated together with IMT. The aim to improve the management of SLE while preventing major vascular involvements would be a promising perspective, but would only be possible if the clinicians were able to recognize ATS when it is still in a subclinical form.
The clinical impact of an early diagnosis of subclinical ATS in SLE is so far unknown; however, the possibility of regulating immunomodulatory and immunosuppressive treatments and modifying lifestyle, as well as treating the classical cardiovascular risk differently, might reduce the adverse effects of ATS on clinical outcomes, preventing or delaying the development of major vascular complications. The need to reduce treatment costs caused by vascular complications that affect SLE patients is another reason to improve strategies that prevent them.
The use of non-invasive imaging techniques may have a great effect in predicting subclinical ATS through the evaluation of endothelial dysfunction, vascular stiffness and IMT, and may represent a correct approach available today to prevent and better manage vascular complications in SLE. The lack of reproducibility and agreement between the different techniques is a clear limitation and suggests their combined use in prospective cohorts.
New randomized controlled trials are needed to prove the best methods revealing these predictors of subclinical ATS, to choose the optimal interval to screen SLE patients and suggest guidelines on treatment recommendations. FIG. 1 Measurement of carotid vascular wall excursions over three heart cycles. Right (!) indicates minimum diameter and left (!) maximum diameter. maxDIA: maximum common carotid diameter; minDIA: minimum common carotid diameter; sBP: systolic blood pressure; dBP: diastolic blood pressure; k: conversion factor from mmHg to Pa (k = 7 Â 10 À3 ).
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